Literature DB >> 9708554

In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.

N De Stefano1, Z Caramanos, M C Preul, G Francis, J P Antel, D L Arnold.   

Abstract

We used computer pattern recognition of proton magnetic resonance spectroscopic image data to differentiate between brain tumors and large, isolated, demyelinating lesions of the type seen in multiple sclerosis. Leave-one-out linear discriminant analyses correctly classified resonance profiles from five acute demyelinating lesions, 20 low-grade astrocytomas, 22 anoplastic astrocytomas, and 24 glioblastomas. Classification of nonacute lesions will require further development, as the metabolic profiles of demyelinating lesions evolve over time.

Entities:  

Mesh:

Year:  1998        PMID: 9708554     DOI: 10.1002/ana.410440222

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

Review 1.  MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.

Authors:  M Essig; N Anzalone; S E Combs; À Dörfler; S-K Lee; P Picozzi; A Rovira; M Weller; M Law
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-20       Impact factor: 3.825

Review 2.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

3.  Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors.

Authors:  A Lin; S Bluml; A N Mamelak
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

4.  Effect of voxel position on single-voxel MR spectroscopy findings.

Authors:  P E Ricci; A Pitt; P J Keller; S W Coons; J E Heiserman
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

5.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

6.  Homonymous hemianopsia as the leading symptom of a tumor like demyelinating lesion: a case report.

Authors:  Maria Eleptheria Evangelopoulos; Dimitrios Stergios Evangelopoulos; Costas Potagas; Costantinos Sfagos
Journal:  Cases J       Date:  2009-12-21

Review 7.  Quantitative imaging biomarkers in neuro-oncology.

Authors:  Adam D Waldman; Alan Jackson; Stephen J Price; Christopher A Clark; Thomas C Booth; Dorothee P Auer; Paul S Tofts; David J Collins; Martin O Leach; Jeremy H Rees
Journal:  Nat Rev Clin Oncol       Date:  2009-06-23       Impact factor: 66.675

8.  Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?

Authors:  R Hourani; L J Brant; T Rizk; J D Weingart; P B Barker; A Horská
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-30       Impact factor: 3.825

Review 9.  Idiopathic inflammatory-demyelinating diseases of the central nervous system.

Authors:  A Rovira Cañellas; A Rovira Gols; J Río Izquierdo; M Tintoré Subirana; X Montalban Gairin
Journal:  Neuroradiology       Date:  2007-02-28       Impact factor: 2.995

Review 10.  Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes.

Authors:  Ema Kantorová; Michal Bittšanský; Štefan Sivák; Eva Baranovičová; Petra Hnilicová; Vladimír Nosáľ; Daniel Čierny; Kamil Zeleňák; Wolfgang Brück; Egon Kurča
Journal:  BMC Cancer       Date:  2017-06-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.